Publishing research using ab57752? Please let us know so that we can cite the reference in this datasheet.

ab57752 has been referenced in 7 publications.

  • Saunders JH  et al. Individual patient oesophageal cancer 3D models for tailored treatment. Oncotarget 8:24224-24236 (2017). IHC-P, ICC/IF ; Human . PubMed: 27736801
  • El-Balat A  et al. TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary. Pathol Oncol Res N/A:N/A (2017). IHC-P ; Human . PubMed: 28470574
  • Busch RA  et al. Bombesin Preserves Goblet Cell Resistin-Like Molecule ß During Parenteral Nutrition but Not Other Goblet Cell Products. JPEN J Parenter Enteral Nutr 40:1042-9 (2016). PubMed: 25934045
  • Hoellen F  et al. Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parameters. Mol Clin Oncol 5:422-428 (2016). IHC ; Human . PubMed: 27699037
  • Ding A  et al. Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer. PLoS One 8:e82136 (2013). IHC-P ; Human . PubMed: 24358147
  • Iwasaki M  et al. Longitudinal cell formation in the entire human small intestine is correlated with the localization of Hath1 and Klf4. J Gastroenterol 46:191-202 (2011). IHC-P ; Human . PubMed: 21125297
  • Mostaghel EA  et al. Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention. Cancer Res 70:1286-95 (2010). IHC-P ; Human . PubMed: 20124490

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up